We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-19.74%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$2B
AUM Growth
+$181M
Cap. Flow
-$182M
Cap. Flow %
-9.13%
Top 10 Hldgs %
62.34%
Holding
416
New
102
Increased
87
Reduced
79
Closed
120

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$21.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$21.2M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.1M
4
BIIB icon
Biogen
BIIB
+$9.79M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$8.84M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$33.1M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$7.45M
3
MBLY
Mobileye N.V.
MBLY
+$7.26M
4
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$5.86M
5
ASXC
Asensus Surgical, Inc.
ASXC
+$5.01M

Sector Composition

Rank Sector Weight
1 Healthcare 11.94%
2 Consumer Staples 0.06%
3 Industrials 0.04%
4 Technology 0.04%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASXC
351
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-117,039
Closed -$5.01M
THMO
352
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
– –
-236
Closed -$387K
ACER
353
DELISTED
Acer Therapeutics Inc
ACER
– –
-9,530
Closed -$10K
INFI
354
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-1,971
Closed -$1.55M
NUVA
355
DELISTED
NuVasive, Inc.
NUVA
– –
-15,000
Closed -$812K
ACGN
356
CALL
DELISTED
Aceragen Inc
ACGN
– –
-20
Closed -$836K
MTEM
357
CALL
DELISTED
Molecular Templates, Inc.
MTEM
– –
-7
Closed -$58K
BLCM
358
CALL
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-293
Closed -$5.93M
BLCM
359
PUT
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-33
Closed -$659K
ALBO
360
PUT
DELISTED
Albireo Pharma Inc
ALBO
– –
-6
Closed -$6K
LCI
361
CALL
DELISTED
Lannett Company, Inc.
LCI
– –
-129
Closed -$2.07M
AERI
362
CALL
DELISTED
Aerie Pharmaceuticals
AERI
– –
-215
Closed -$524K
ENDP
363
CALL
DELISTED
Endo International plc
ENDP
– –
-1,075
Closed -$6.58M
ENDP
364
PUT
DELISTED
Endo International plc
ENDP
– –
-55
Closed -$337K
RDUS
365
CALL
DELISTED
Radius Health, Inc.
RDUS
– –
-578
Closed -$3.56M
HSTO
366
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-441
Closed -$254K
CSLT
367
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
– –
-106,500
Closed -$455K
ADMS
368
CALL
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-243
Closed -$688K
ALXN
369
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-152
Closed -$2.9M
GWPH
370
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-100
Closed -$694K
PTLA
371
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-3,900
Closed -$124K
PTLA
372
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-218
Closed -$1.12M
ONCE
373
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-770
Closed -$3.49M
GNCA
374
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-19,517
Closed -$823K
ELGX
375
DELISTED
Endologix Inc
ELGX
– –
-10,000
Closed -$990K
13 14
15
16 17

Similar funds

NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Sabby Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sabby Management held 416 positions worth $2B, up 9.9% from $1.82B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sabby Management withdrew a net $182M in Q1 2016, closing 120 positions and reducing 79 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $33.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Sabby Management opened a new position in Amgen worth $21.5M.

  • Sabby Management's largest Q1 2016 buy was Amgen: 143,486 shares worth $21.5M.
  • Sabby Management added most to Northwest Biotherapeutics, Inc. Common stock in Q1 2016, an estimated $4.73M increase.
  • Sabby Management's biggest Q1 2016 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $7.45M.
  • Sabby Management fully exited iShares Russell 2000 ETF in Q1 2016, selling an estimated $33.1M.
  • Sabby Management's ten largest holdings make up 62% of its $2B portfolio in Q1 2016.
  • Sabby Management opened 102 new positions and closed 120 in Q1 2016.
  • Sabby Management's portfolio value rose 9.9% quarter-over-quarter to $2B.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.